Published
Combining NVIDIA's world-leading accelerated computing and Schrödinger's novel drug discovery platform enables rapid, accurate evaluation of billions of molecules for the potential development of therapeutics, reducing the cost of preclinical drug discovery. Learn more: https://nvda.ws/3fUH2JF
#drugresearch #drugdevelopment #machinelearning
#drugresearch #drugdevelopment #machinelearning
Sign in or sign up to post comments.
Be the first to comment
Up Next
-
02:36
How NVIDIA GPUs Accelerate Adobe Illustrator CC
-
07:43
Accelerate Innovation with NVIDIA and Dell Technologies
-
13:04
Satya Nadella: Worldwide Partner Conference 2016
-
01:31
Accelerate Production Ready AI with NVIDIA AI Enterprise
-
03:32
U.S. Building Two Flagship Supercomputers to Accelerate Scientific Discovery
-
02:06
NVIDIA and Arm Accelerate HPC Worldwide
-
02:33
Genentech and NVIDIA Revolutionize Drug Discovery with Generative AI in Lab in the Loop
-
01:12
Generative AI for Drug Discovery and Design
-
03:29
U.S. Building 2 Flagship Supercomputers to Accelerate Scientific Discovery
-
01:19
Using AI to Accelerate Scientific Discovery
-
04:27
Microsoft Azure Quantum and PNNL join forces to accelerate scientific discovery
-
02:20
AstraZeneca: Accelerating Drug Discovery with Machine Learning and AI on Cambridge-1
-
01:14
GSK and NVIDIA Partner on AI-Powered Lab for Discovery of Medicines and Vaccines
-
01:07
Intel and NVIDIA Accelerate Professional Workstation Performance
-
01:14
Altair and NVIDIA GPUs Accelerate Design Simulation
-
02:24
Accelerate AI-Powered Drug Discovery With NVIDIA BioNeMo
-
02:13
Accelerate AI Workloads for Healthcare with NVIDIA and VMware
-
03:54
Worldwide Partner Conference: Day 1 Recap
-
00:40
Drug Discovery Set for Deep Learning Transformation Powered by GPUs
-
02:07
Accelerate Breakthroughs with NVIDIA GPU Cloud
-
02:05
WORLDWIDE NVIDIA SHIELD GIVEAWAY!!
-
01:46
Accelerate Production-Ready AI with NVIDIA AI Enterprise
Loading...